AA
BIVV

AQR Arbitrage’s Bioverativ Inc. Common Stock BIVV Stock Holding History

AQR Arbitrage’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-924,878
Closed -$49.9M – 453
2017
Q4 		$49.9M Buy
924,878
+456,806
+98% +$25M 0.59% 43
2017
Q3 		$26.7M Sell
468,072
-96,603
-17% -$5.66M 0.29% 82
2017
Q2 		$34M Sell
564,675
-33,850
-6% -$1.93M 0.37% 71
2017
Q1 		$32.6M Buy
+598,525
New +$29.5M 0.37% 70

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

AQR Arbitrage's BIVV Position: Q1 2018 in Review

AQR Arbitrage sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 924,878 shares — an estimated $49.9M sold.

AQR Arbitrage first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $49.9M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • AQR Arbitrage reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • AQR Arbitrage sold 924,878 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $49.9M.
  • AQR Arbitrage first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • AQR Arbitrage's Bioverativ Inc. Common Stock position peaked at $49.9M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on AQR Arbitrage's 13F filing for Q1 2018, filed 15 May 2018.